SNOA (Sonoma Pharmaceuticals, Inc. Common Stock) Stock Analysis - Politician Trades

Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) is a publicly traded Healthcare sector company. As of May 21, 2026, SNOA trades at $1.11 with a market cap of $3.58M and a P/E ratio of -0.38. SNOA moved +4.46% today. Year to date, SNOA is -71.31%; over the trailing twelve months it is -67.48%. Its 52-week range spans $0.85 to $6.92. Rallies surfaces SNOA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded SNOA stock?

Rallies tracks politician and congressional stock disclosures for SNOA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

SNOA Key Metrics

Key financial metrics for SNOA
MetricValue
Price$1.11
Market Cap$3.58M
P/E Ratio-0.38
EPS$-2.79
Dividend Yield0.00%
52-Week High$6.92
52-Week Low$0.85
Volume5.25K
Avg Volume0
Revenue (TTM)$14.29M
Net Income$-2.91M
Gross Margin38.25%

Latest SNOA News

SNOA Analyst Consensus

SNOA analyst coverage data. Average price target: $0.00.

Common questions about SNOA

Which politicians traded SNOA stock?
Rallies tracks politician and congressional stock disclosures for SNOA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in SNOA?
Yes. Rallies tracks politician and congressional stock disclosures for SNOA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is SNOA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNOA. It does not provide personalized investment advice.
SNOA

SNOA